Literature DB >> 14630508

Quantitative positron emission tomography imaging to measure tumor response to therapy: what is the best method?

David A Mankoff, Mark Muzi, Kenneth A Krohn.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14630508     DOI： 10.1016/j.mibio.2003.09.002

Source DB:  PubMed          Journal:  Mol Imaging Biol        ISSN： 1536-1632            Impact factor:   3.488


× No keyword cloud information.
  11 in total

Review 1.  Current and future use of positron emission tomography (PET) in breast cancer.

Authors:  David A Mankoff; William B Eubank
Journal:  J Mammary Gland Biol Neoplasia       Date:  2006-04       Impact factor: 2.673

2.  Anti-Angiogenic/Vascular Effects of the mTOR Inhibitor Everolimus Are Not Detectable by FDG/FLT-PET.

Authors:  Michael Honer; Thomas Ebenhan; Peter R Allegrini; Simon M Ametamey; Mike Becquet; Catherine Cannet; Heidi A Lane; Terence M O'Reilly; Pius A Schubiger; Melanie Sticker-Jantscheff; Michael Stumm; Paul Mj McSheehy
Journal:  Transl Oncol       Date:  2010-08-01       Impact factor: 4.243

3.  PET tumor metabolism in locally advanced breast cancer patients undergoing neoadjuvant chemotherapy: value of static versus kinetic measures of fluorodeoxyglucose uptake.

Authors:  Lisa K Dunnwald; Robert K Doot; Jennifer M Specht; Julie R Gralow; Georgiana K Ellis; Robert B Livingston; Hannah M Linden; Vijayakrishna K Gadi; Brenda F Kurland; Erin K Schubert; Mark Muzi; David A Mankoff
Journal:  Clin Cancer Res       Date:  2011-03-01       Impact factor: 12.531

4.  Multi-observation PET image analysis for patient follow-up quantitation and therapy assessment.

Authors:  S David; D Visvikis; C Roux; M Hatt
Journal:  Phys Med Biol       Date:  2011-08-16       Impact factor: 3.609

5.  Exploring temporospatial changes in glucose metabolic disorder, learning, and memory dysfunction in a rat model of diffuse axonal injury.

Authors:  Jia Li; Lei Gu; Dong-Fu Feng; Fang Ding; Guangyao Zhu; Jiandong Rong
Journal:  J Neurotrauma       Date:  2012-11-20       Impact factor: 5.269

6.  Dynamic and static approaches to quantifying 18F-FDG uptake for measuring cancer response to therapy, including the effect of granulocyte CSF.

Authors:  Robert K Doot; Lisa K Dunnwald; Erin K Schubert; Mark Muzi; Lanell M Peterson; Paul E Kinahan; Brenda F Kurland; David A Mankoff
Journal:  J Nucl Med       Date:  2007-05-15       Impact factor: 10.057

7.  Role of PET quantitation in the monitoring of cancer response to treatment: Review of approaches and human clinical trials.

Authors:  Robert K Doot; Elizabeth S McDonald; David A Mankoff
Journal:  Clin Transl Imaging       Date:  2014-08-01

Review 8.  Analysis of Four-Dimensional Data for Total Body PET Imaging.

Authors:  Varsha Viswanath; Rhea Chitalia; Austin R Pantel; Joel S Karp; David A Mankoff
Journal:  PET Clin       Date:  2021-01

9.  Measuring response to therapy using FDG PET: semi-quantitative and full kinetic analysis.

Authors:  Patsuree Cheebsumon; Linda M Velasquez; Corneline J Hoekstra; Wendy Hayes; Reina W Kloet; Nikie J Hoetjes; Egbert F Smit; Otto S Hoekstra; Adriaan A Lammertsma; Ronald Boellaard
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-01-06       Impact factor: 9.236

10.  Multivariate analysis of various factors affecting background liver and mediastinal standardized uptake values.

Authors:  Manohar Kuruva; Bhagwant Rai Mittal; Mohammed Labeeb Abrar; Raghava Kashyap; Anish Bhattacharya
Journal:  Indian J Nucl Med       Date:  2012-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.